drugset
drugset / Trial / NCT07434960

Expanded Access for Iberdomide

NCT07434960 ↗

Expanded access Available Bristol-Myers Squibb

Summary

This is an expanded access designed to provide access to Iberdomide for eligible participants.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Background Iberdomide Small molecule — —

Indications

No indication recorded.